Publications

127 1982 medicines and the quality of life

Medicines and the Quality of Life

1 September 1982

Previous studies concerned with the benefits of modern medicines have concentrated mainly on their economic consequences (Wells NEJ 1980; Teeling-Smith G 1982). By contrast this paper…

124 - 1982 coronary heath disease

Coronary Heart Disease: the Scope for Prevention

1 August 1982

One person in every four in England and Wales dies from coronary heart disease and at a minimum estimate the costs borne by the National Health…

128 - 1982 medicines, health and the poor

Medicines, Health and the Poor World

1 April 1982

In 1972 the Office of Health Economics produced a paper entitled Medical Care in Developing Countries. Drawing on both information available within the pharmaceutical industry and…

125 - 1982 hip replacement and the NHS

Hip Replacement in the NHS

1 March 1982

Of all forms of joint replacement operation, that for hips represents the most outstanding innovation. It is perhaps the major post-war surgical development and the key…

129 - 1982 the costs and benefits of regulating

Costs and Benefits of Regulating New Product Development in the UK Pharmaceutical Industry

3 January 1982

This is the second in an occasional series of Pharmaceutical Industry Papers to be published by OHE. The first concerned prices; this second paper is concerned,…

Cracks through the ice on a melting glacier in Alaska

Doctors, Nurses and Midwives in the NHS

1 November 1981

There have been substantial increases in all categories of professional manpower in the National Health Service since it was first established in 1949. This Briefing examines…

113 - 1981 accidents in childhood

Accidents in childhood

1 September 1981

During the last 30 years the proportion of deaths occurring in childhood caused by accidents has risen from 21 to 30 per cent. This development is…

119 - 1981 Price Comparisons of Identical projects

Price Comparisons of Identical Products in Japan, the United States and Europe

1 August 1981

The promotion of an environment in which the multinational research-based pharmaceutical industry can flourish has been and will continue to be reliant upon a well-informed and…

120 - 1981 sickness absence

Sickness Absence – A Review

8 January 1981

Absence from work stems from a variety of sources including industrial action, lateness and ill-health. Of these the latter is by far the most significant cause…